1. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay – a systematic review

   • Lateef Mohiuddin Khan

   Review Article 17 August 2013 Pages: 1985 - 1996

   

2. A cytochrome P450 phenotyping cocktail causing unexpected adverse reactions in female volunteers

   • Rasmus Steen Pedersen
   • Per Damkier
   • Kim Brosen

   Clinical Trial 06 August 2013 Pages: 1997 - 1999

3. Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: a systematic review and meta-analysis

   • Y. L. Yan
   • B. Qiu
   • Q. She

   Clinical Trial 14 August 2013 Pages: 2001 - 2009

   

4. The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor

   • William Kielbasa
   • Eshetu Tesfaye
   • Michael A. Turik

   Clinical Trial Open access 17 August 2013 Pages: 2011 - 2019

   

5. Pregabalin abuse among opiate addicted patients

   • Martin Grosshans
   • Tagrid Lemenager
   • Derik Hermann

   Clinical Trial 30 August 2013 Pages: 2021 - 2025

6. Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension

   • Thiago Quinaglia
   • Ana Paula C. de Faria
   • Heitor Moreno

   Pharmacodynamics 21 August 2013 Pages: 2027 - 2036

   

7. Relative efficacy and effectiveness assessment of new pharmaceuticals in three EU member states: current practices and outcome agreement between Belgium, the Netherlands and France

   • P. B. Van Wilder
   • V. V. Bormans
   • A. G. Dupont

   Pharmacoeconomics 01 September 2013 Pages: 2037 - 2043

8. Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C

   • C. Xu
   • S. Gupta
   • V. Sniukiene

   Pharmacokinetics and Disposition 24 August 2013 Pages: 2045 - 2054

   

9. Practical recommendations for population PK studies with sampling time errors

   • Leena Choi
   • Ciprian M. Crainiceanu
   • Brian S. Caffo

   Pharmacokinetics and Disposition 24 August 2013 Pages: 2055 - 2064

   

10. The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand–foot syndrome

    • Nienke A. G. Lankheet
    • Alwin D. R. Huitema
    • Christian U. Blank

    Pharmacokinetics and Disposition 31 August 2013 Pages: 2065 - 2072

    

11. Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors

    • Huali Wu
    • Jeffrey R. Infante
    • William C. Zamboni

    Pharmacokinetics and Disposition 30 August 2013 Pages: 2073 - 2081

    

12. Sources of information used by regulatory agencies on the generation of drug safety alerts

    • Carlos Alves
    • Ana Filipa Macedo
    • Francisco Batel Marques

    Pharmacoepidemiology and Prescription 27 July 2013 Pages: 2083 - 2094

    

13. Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence

    • Elisabetta Poluzzi
    • Carlo Piccinni
    • Fabrizio De Ponti

    Pharmacoepidemiology and Prescription 01 August 2013 Pages: 2095 - 2101

14. NSAIDs and nephrocalcinosis

    • Ieuan Evans
    • Ian Penman
    • Neeraj Dhaun

    Letter to the Editors 06 August 2013 Pages: 2103 - 2104